Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review

The insulin analogs lispro, aspart, and glulisine are the only commercially available rapid-acting insulins to treat diabetes. We review the evidence for treating hyperglycemia, using insulin, and specifically using rapid-acting analogs in diabetic individuals, on the prevention of vascular events....

Descripción completa

Detalles Bibliográficos
Autores principales: Fordan, Steve, Raskin, Philip
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672433/
https://www.ncbi.nlm.nih.gov/pubmed/19436644
_version_ 1782166535252475904
author Fordan, Steve
Raskin, Philip
author_facet Fordan, Steve
Raskin, Philip
author_sort Fordan, Steve
collection PubMed
description The insulin analogs lispro, aspart, and glulisine are the only commercially available rapid-acting insulins to treat diabetes. We review the evidence for treating hyperglycemia, using insulin, and specifically using rapid-acting analogs in diabetic individuals, on the prevention of vascular events. We review the beneficial effects of insulin on the vascular system, which include vasodilation and anti-inflammatory actions. The effects of treating hyperglycemia and intensive blood glucose control on vascular outcomes are reviewed.
format Text
id pubmed-2672433
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26724332009-08-08 Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review Fordan, Steve Raskin, Philip Vasc Health Risk Manag Review The insulin analogs lispro, aspart, and glulisine are the only commercially available rapid-acting insulins to treat diabetes. We review the evidence for treating hyperglycemia, using insulin, and specifically using rapid-acting analogs in diabetic individuals, on the prevention of vascular events. We review the beneficial effects of insulin on the vascular system, which include vasodilation and anti-inflammatory actions. The effects of treating hyperglycemia and intensive blood glucose control on vascular outcomes are reviewed. Dove Medical Press 2009 2009-04-08 /pmc/articles/PMC2672433/ /pubmed/19436644 Text en © 2009 Dove Medical Press Limited. All rights reserved
spellingShingle Review
Fordan, Steve
Raskin, Philip
Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
title Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
title_full Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
title_fullStr Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
title_full_unstemmed Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
title_short Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
title_sort vascular effects of rapid-acting insulin analogs in the diabetic patient: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672433/
https://www.ncbi.nlm.nih.gov/pubmed/19436644
work_keys_str_mv AT fordansteve vasculareffectsofrapidactinginsulinanalogsinthediabeticpatientareview
AT raskinphilip vasculareffectsofrapidactinginsulinanalogsinthediabeticpatientareview

Ejemplares similares